The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season.

President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing Thursday that, if confirmed as FDA commissioner, he plans to evaluate school lunches,

The cancellation plays into fears among scientists who worry that Robert F. Kennedy Jr. will use his position as health secretary to sow doubts about vaccines.

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.

The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took control of HHS.

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug Administration — have now been disrupted under the watch of US Health and Human Services Secretary Robert F.

An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.

The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in their shots for the next flu season.

The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.

The meeting is the second federal vaccine panel meeting Trump administration officials have canceled or postponed since RFK Jr. took over HHS.

Feb. 27 (UPI) --The Food and Drug Administration abruptly and unexpectedly canceled a planned March 13 vaccine advisory committee meeting that was to have chosen the flu strains in next year's U.S ...